Vesuvius India Limited announces an acquisition

The carrying value (Net Book Value) of the assets and liabilities associated with the Mehsana facility and the estimated accounting profit or loss arising from the INR 43.25 crore slump sale are not separately disclosed in the company's financial statements and regulatory filings.

As of the latest reported balance sheet for Q4 FY26, Vesuvius India's overall balance sheet scale stands at total assets of Rs 2,149.6 Crores ^[1], non-current assets of Rs 727.88 Crores ^[2] (including property, plant, and equipment of Rs 622.03 Crores ^[3]), and total equity of Rs 1,663.9 Crores ^[4]. Individual facility-level asset and liability segregations, as well as specific transaction accounting for the Mehsana slump sale, are absent from the reported disclosures.

Financial Contribution (FY Ended December 31, 2025)

According to the slump sale disclosure filed under Regulation 30 of the SEBI Listing Regulations on August 13, 2026, the financial contribution of the Mehsana manufacturing facility to Vesuvius India Limited (VIL) for the preceding financial year was as follows:

• Turnover / Revenue: Rs 58.13 Crores, which represented 2.80% of total consolidated revenue for the financial year ended December 31, 2025 `<sup>[5]</sup>`.
• EBITDA Contribution: Not separately disclosed. The regulatory disclosure reports turnover and net-worth metrics, but does not provide an EBITDA break-up or EBITDA contribution percentage for the Mehsana unit `<sup>[5]</sup>`.
• Net Worth Contribution: Rs 34.74 Crores, representing 2.09% of VIL's total net worth for the financial year ended December 31, 2025 `<sup>[5]</sup>`.
• Transaction Consideration: Slump sale consideration of Rs 43.25 Crores agreed with buyer Foseco India Limited, expected to close by December 31, 2026 `<sup>[6]</sup>`, `<sup>[5]</sup>`.

---

Impact on Overall Production Capacity

• Quantitative Capacity Disclosure Gap: The slump sale filing does not disclose specific volumetric installed or operational manufacturing capacity metrics (such as metric tonnes per annum or percentage of total company plant capacity) for the Mehsana unit `<sup>[6]</sup>`.
• Product Scope Divested: The Mehsana plant comprises a manufacturing facility primarily engaged in producing crucibles, stoppers, and sleeves designed for the non-ferrous industrial sector `<sup>[6]</sup>`.
• Strategic & Operational Implication: Management classified the Mehsana manufacturing unit as non-core to Vesuvius India's core refractory strategy (while serving as a core asset for buyer Foseco India Limited's non-ferrous foundry operations) `<sup>[6]</sup>`. Given its small contribution to overall top-line financial performance (2.80% of revenue) `<sup>[5]</sup>`, the divestment rationalizes non-core non-ferrous capacity without impacting VIL's main refractory manufacturing scale and primary business focus `<sup>[6]</sup>`.

Vesuvius India Limited’s slump sale of its Mehsana, Gujarat manufacturing facility to Foseco India Limited (FIL) for a lump-sum consideration of Rs 43.25 crore is targeted for completion by December 31, 2026 ^[7].

Transaction Timeline and Consideration

• Consideration: Rs 43.25 crore structured as a lump-sum cash consideration for the slump sale of the Mehsana facility, which manufactures crucibles, stoppers, and sleeves for the non-ferrous industrial sector ^[7].
• Stated Timeline: The transaction is anticipated to conclude by December 31, 2026 ^[7]. The company has confirmed there will be no impact on its shareholding pattern ^[7].

Conditions Precedent and Governance

• Disclosed Governance Approvals: The transaction has received approval from Vesuvius India’s Board of Directors and Audit Committee on an arm’s length basis, supported by a formal valuation report from BDO Valuation Advisory LLP ^[7].
• Disclosure Gap: Specific conditions precedent—such as third-party consents, specific statutory regulatory clearances, or creditor approvals required to consummate the transfer—are not separately detailed in the available disclosures ^[7].